Posted in | News | Petrochemicals

Zimmer to Build PET Bottle Plant in Russia

Zimmer AG, Frankfurt am Main, a subsidiary of MG Technologies AG, has won a contract to build a polyester plant for the manufacture of chips for polyester (PET) bottles in Russia. The order is worth approximately €40 million. The customer is Petrochemical Holding AG, an internationally active Austrian investment group based in Vienna. The plant will produce 154,000 tonnes of polyester chips per year and will be located in Dzerzhinsk, near Nizhny Novgorod. Zimmer is supplying the technology, the engineering facilities and the equipment and is responsible for supervising the plant's assembly and commissioning, which is scheduled for the second half of 2006.

"This contract will enable Zimmer to further extend its strong position in the field of PET plants in the rapidly growing eastern European market", emphasized Klaus Moll, who is responsible for plant engineering in the mg management board. "Once this plant has been completed, over half a million tonnes of PET chips per year will be produced with Zimmer's technology in eastern Europe."

In November 2003 and March of this year, Zimmer won contracts from Petrochemical Holding AG to build two PET plants in Lithuania, each with an annual capacity of 154,000 tonnes. These plants are due to come on stream in 2005. The first plant built by Zimmer in eastern Europe - with the capacity to produce 55,000 tonnes of chips for PET bottles per year - was recently brought on stream in Russia. Petrochemical Holding AG and Zimmer have already signed a letter of intent to construct a fifth plant in the region.

For more information on PET, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.